ADI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ADI is a good buy right now for a beginner-focused, long-term investor with $50,000-$100,000 available. The stock shows a constructive technical setup, strong Q1 financial acceleration, and broad Wall Street support with rising price targets. While there is no special Intellectia buy signal today and congress activity shows slight selling, the overall setup still favors buying now rather than waiting.
ADI is in a short-term uptrend with bullish moving averages (SMA 5 > SMA 20 > SMA 200), which is a positive sign for trend continuation. MACD histogram is above zero at 1.15, though it is positively contracting, suggesting momentum is still bullish but has eased somewhat. RSI_6 at 65.35 is near the upper end of neutral, so the stock is not overextended enough to disqualify a purchase. Price at 413.57 is just below resistance at 411.987/419.905 after a modest daily decline, and it remains above the pivot at 399.171, indicating the broader trend is intact.
["Q1 2026 revenue rose 30.42% YoY to 3.16B", "Net income jumped 112.32% YoY and EPS grew 116.67% YoY", "Gross margin improved to 58.78%, signaling strong profitability", "Analysts have repeatedly raised price targets and kept Buy/Overweight ratings", "Citi flagged an upside 30-day catalyst watch", "ADI has bullish moving averages and remains above its pivot support"]
["No AI Stock Picker signal today", "No recent SwingMax signal", "Congress trading data shows 1 recent sale and no purchases", "Options volume put-call ratio is bearish at 1.51", "MACD momentum is still positive but contracting", "The stock closed lower on the day"]
In Q1 2026, ADI posted very strong growth: revenue increased to 3.16B, up 30.42% YoY. Net income rose 112.32% YoY to 830.8M, EPS increased 116.67% YoY to 1.69, and gross margin improved to 58.78% (+14.60% YoY). This is a strong latest-quarter season and shows clear improvement in both growth and profitability.
Wall Street is clearly positive on ADI. Goldman Sachs raised its target to $415 and kept Buy; BofA raised to $425 and kept Buy; Citi maintained Buy and added an upside catalyst watch; Arete upgraded to Buy; Needham upgraded to Buy; JPMorgan, Susquehanna, Stifel, and Morgan Stanley all remained constructive with higher targets. The pros view is that ADI has strong margins, pricing power, cyclical recovery, and AI-related upside. The main con is that expectations are now high after multiple target increases, but the overall analyst trend is still strongly bullish.
